– Report details the company s dedication to healthcare for humanity through sustainable practices coupled with progress towards its mission –
SAN FRANCISCO, March 15, 2022. | March 15, 2022
/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today released its 2022 Environmental, Social and Governance (ESG) Report summarizing.
/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today released its 2022 Environmental, Social and Governance (ESG) Report summarizing.
Invitae (NVTA) Q2 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective.